Terlipressin. Type I hepatorenal syndrome: an extra window of time before liver transplantation.
In some patients with type I hepatorenal syndrome, a retrospective study suggests, albeit with a low level of evidence, that terlipressin increases survival time by about a week, which sometimes allows enough time to find a suitable liver donor. Adverse effects due to the vasoconstrictive action of terlipressin require close monitoring during treatment.